1. The PanCareSurFup cohort of 83,333 five-year survivors of childhood cancer: a cohort from 12 European countries;Grabow;Eur J Epidemiol,2018
2. Evolving synergistic combinations of targeted immunotherapies to combat cancer;Melero;Nat Rev Cancer,2015
3. Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial;Geoerger,2020
4. Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma;Geoerger;Eur J Cancer,2017
5. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908;Dunkel;Neuro Oncol,2023